Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):55–68. doi: 10.1517/17425250903393752

Figure 3.

Figure 3

Nevirapine Cmax (A), Cmin (B) and AUC (C) in 13 patients with HIV and tuberculosis in the absence and presence of rifampicin. Nevirapine and rifampicin were administered at standard dosage and patients were in steady state. Rifampicin co-administration caused a mean reduction in Cmax by 42%, Cmin by 53% and AUC by 46%.